TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evidence Based Training and Physical Activity With an E-health Program - a New Method for People With Chronic Obstructive Pulmonary Disease (COPD) to Become More Physically Active.
Brief Summary: The main aim of the project in this application is two-fold. First we will explore and describe facilitators and barriers for being physically active and perform physical training for people with Chronic Obstructive Pulmonary Disease COPD (Step 1). Secondly, with user involvement, we will develop and evaluate a novel e-health program with a training module and an evidence-based educational component, the rEACH-COPD e-health program with the aim to increase the understanding and management of the disease and to facilitate every-day living with COPD (Step 2-3).

According to the guidelines of the Swedish National Board of Health and Welfare (SoS), physiotherapy led exercise is an important part of rehabilitation for people with COPD. The e-health training program will follow evidence-based guidelines, i.e. recommendations from SoS and the American College of Sport Medicine (ACSMS).

Offering individualized and evidence-based training will increase adherence to training. With regular physical activity and exercise there is a potential to improve health-related quality of life, physical capacity, activity and participation in every day life in people with COPD.

By an improved health, physical function and quality of life a decreased use of health care is expected. Thus, this program may, in the long term, contribute to reduced costs for the society.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Training with e-health product | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual care | Intervention Type: OTHER; Name: Training with e-health product; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): Control
B: Arm Label: HappyAir Group; Type: EXPERIMENTAL; Interventions: Other: Pulmonary Care Web-Based App (HappyAir App) | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Pulmonary Care Web-Based App (HappyAir App); Assigned to Arm(s): HappyAir Group
C: Arm Label: Intercom; Type: EXPERIMENTAL; Interventions: Other: INTERdisciplinary COMmunity-based COPD management (INTERCOM) | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: INTERdisciplinary COMmunity-based COPD management (INTERCOM); Assigned to Arm(s): Intercom
D: Arm Label: Activity-Self Management; Type: EXPERIMENTAL; Interventions: Behavioral: Self-Management and Motivational Interviewing | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Self-Management and Motivational Interviewing; Assigned to Arm(s): Activity-Self Management

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effect of Lactobacillus Rhamnosus (LGG®) on the Defence Against Pathogens in the Upper Respiratory Tract in Healthy Children - a Single-center, Randomized, Double-blind, Placebo-controlled Study With 16 Weeks Intervention.
Brief Summary: This study is a randomized, double-blind, placebo-controlled, two-armed, parallel-group study in healthy children aged 2-6 years. The study will investigate the effect of daily intake of a probiotic on Upper Respiratory Tract Infections (URTI) during a 16-week intervention.


Options:
A: Arm Label: Lactobacillus; Type: EXPERIMENTAL; Interventions: Biological: Lactobacillus reuteri | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: Lactobacillus reuteri; Assigned to Arm(s): Lactobacillus | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Probiotics; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Probiotic | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Probiotic; Assigned to Arm(s): Probiotics | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: 1; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: low calcium milk of 180 ml | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: regular milk of 180 ml | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: regular milk of 180 ml + probiotics | Arm Label: 4; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: regular milk of 180 ml + probiotics | Intervention Type: DIETARY_SUPPLEMENT; Name: low calcium milk of 180 ml; Assigned to Arm(s): 1 | Intervention Type: DIETARY_SUPPLEMENT; Name: regular milk of 180 ml; Assigned to Arm(s): 2 | Intervention Type: DIETARY_SUPPLEMENT; Name: regular milk of 180 ml + probiotics; Assigned to Arm(s): 3 | Intervention Type: DIETARY_SUPPLEMENT; Name: regular milk of 180 ml + probiotics; Assigned to Arm(s): 4
D: Arm Label: Probiotic; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Probiotic strain | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Probiotic strain; Assigned to Arm(s): Probiotic | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multicenter, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety and Efficacy of Intravenous CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus, With a 52-Week Open Label Extension
Brief Summary: This is a multicenter, international study to evaluate the safety and efficacy of intravenous (IV) CR845 at a dose of 0.5 mcg/kg administered after each dialysis session. The study includes a 12-week randomized, double-blind, placebo-controlled Phase and a 52-week Open-label Extension Phase.


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Senna; Type: ACTIVE_COMPARATOR; Interventions: Drug: Senna | Intervention Type: DRUG; Name: Senna; Assigned to Arm(s): Senna | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Self Management Strategies; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Self-management | Arm Label: Dietary Information; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Dietary Information | Intervention Type: BEHAVIORAL; Name: Self-management; Assigned to Arm(s): Self Management Strategies | Intervention Type: BEHAVIORAL; Name: Dietary Information; Assigned to Arm(s): Dietary Information
C: Arm Label: Wheat; Type: PLACEBO_COMPARATOR; Interventions: Drug: Wheat | Arm Label: Fumaria; Type: ACTIVE_COMPARATOR; Interventions: Drug: Fumaria | Intervention Type: DRUG; Name: Wheat; Assigned to Arm(s): Wheat | Intervention Type: DRUG; Name: Fumaria; Assigned to Arm(s): Fumaria
D: Arm Label: CR845 0.5mcg/kg; Type: ACTIVE_COMPARATOR; Interventions: Drug: CR845 0.5 mcg/kg | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: CR845 0.5 mcg/kg; Assigned to Arm(s): CR845 0.5mcg/kg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Verify the Safety and Effectiveness of the Cerclage Pessary in the Prevention and Treatment of High-risk Preterm Pregnancy
Brief Summary: Verify the safety and effectiveness of the cerclage pessary in the prevention and treatment of high-risk preterm pregnancy.


Options:
A: Arm Label: Cervical Pessary-Group; Type: EXPERIMENTAL; Interventions: Device: cervical pessary | Arm Label: Control-Group; Type: OTHER; Interventions: Other: Control-Group | Intervention Type: DEVICE; Name: cervical pessary; Assigned to Arm(s): Cervical Pessary-Group | Intervention Type: OTHER; Name: Control-Group; Assigned to Arm(s): Control-Group
B: Arm Label: Progesterone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Progesterone | Arm Label: Progesterone plus Experimental device; Type: EXPERIMENTAL; Interventions: Device: Pessary | Intervention Type: DEVICE; Name: Pessary; Assigned to Arm(s): Progesterone plus Experimental device | Intervention Type: DRUG; Name: Progesterone; Assigned to Arm(s): Progesterone
C: Arm Label: pessary; Type: EXPERIMENTAL; Interventions: Device: pessary | Arm Label: Progesterone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Progesterone | Intervention Type: DRUG; Name: Progesterone; Assigned to Arm(s): Progesterone | Intervention Type: DEVICE; Name: pessary; Assigned to Arm(s): pessary
D: Arm Label: Intravaginal progesterone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Prometrium | Arm Label: Intravaginal progesterone and pessary; Type: EXPERIMENTAL; Interventions: Drug: Prometrium, Device: Dr. Arabin, cerclage pessary perforated | Intervention Type: DRUG; Name: Prometrium; Assigned to Arm(s): Intravaginal progesterone, Intravaginal progesterone and pessary | Intervention Type: DEVICE; Name: Dr. Arabin, cerclage pessary perforated; Assigned to Arm(s): Intravaginal progesterone and pessary

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Study on the Effect of the Universal Decontamination With Daily Bathing With 4% Chlorhexidine Gluconate on the Incidence of Hospital Acquired Infections in Intensive Care Units
Brief Summary: The study will assess the utility of 4% chlorhexidine gluconate (CHG) daily bathing to reduce hospital acquired infections in patients admitted to intensive care units. One group will be daily bathed with 4% CHG and the other group with standard soap.


Options:
A: Arm Label: Chromogenic Arm; Type: ACTIVE_COMPARATOR; Interventions: Other: Chromogenic surveillance | Arm Label: Molecular Arm; Type: ACTIVE_COMPARATOR; Interventions: Other: Molecular surveillance | Intervention Type: OTHER; Name: Chromogenic surveillance; Assigned to Arm(s): Chromogenic Arm | Intervention Type: OTHER; Name: Molecular surveillance; Assigned to Arm(s): Molecular Arm
B: Arm Label: Intervention Arm; Type: EXPERIMENTAL; Interventions: Drug: 4% chlorhexidine gluconate soap-like solution | Arm Label: Control Arm; Type: ACTIVE_COMPARATOR; Interventions: Other: standard soap | Intervention Type: DRUG; Name: 4% chlorhexidine gluconate soap-like solution; Assigned to Arm(s): Intervention Arm | Intervention Type: OTHER; Name: standard soap; Assigned to Arm(s): Control Arm
C: Arm Label: Arm 1: Usual Care-Active Surveillance; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Arm 2: Targeted Decolonization; Type: ACTIVE_COMPARATOR; Interventions: Drug: Chlorhexidine bath and nasal mupirocin | Arm Label: Arm 3: Universal Decolonization; Type: ACTIVE_COMPARATOR; Interventions: Drug: Chlorhexidine bath and nasal mupirocin | Intervention Type: DRUG; Name: Chlorhexidine bath and nasal mupirocin; Assigned to Arm(s): Arm 2: Targeted Decolonization, Arm 3: Universal Decolonization
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: 2% Chlorhexidine gluconate cloth | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: 2% Chlorhexidine gluconate cloth; Assigned to Arm(s): 1

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effect of Integrated Health System Leading, Managing and Governing for Result Model Towards Institutional Delivery Among Staff of Health Facilities in Northwest Ethiopia
Brief Summary: The need for leading people, managing work, and governing organizations never changed over the civilization paths of society. However, people in every pole of the globe observe: over-led and under-managed, over-managed and under-governed, and even out of these organizations. These disparities have remained worse in the health system of developing countries like Ethiopia.

To date, Ethiopia put a goal of ending preventable child and maternal death, in achieving universal healthcare by 2035. Nevertheless, the investment on integrated leadership, management and governance is limited.

Therefore, this study hypothesize that institutional delivery are expressively linked with integrated health system leading, managing and governing for results model among health facilities staff in northwest Ethiopia?


Options:
A: Arm Label: Staff of facilities for intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Integrated leading, managing and governing for results model | Arm Label: Staff of facilities for control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Traditional model | Intervention Type: BEHAVIORAL; Name: Integrated leading, managing and governing for results model; Assigned to Arm(s): Staff of facilities for intervention | Intervention Type: BEHAVIORAL; Name: Traditional model; Assigned to Arm(s): Staff of facilities for control
B: Arm Label: State of the Art strategy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: state-of-the art strategy and extented strategy | Arm Label: extended strategy; Type: EXPERIMENTAL; Interventions: Behavioral: state-of-the art strategy and extented strategy | Intervention Type: BEHAVIORAL; Name: state-of-the art strategy and extented strategy; Assigned to Arm(s): State of the Art strategy, extended strategy
C: Arm Label: Educational Intervention; Type: EXPERIMENTAL; Interventions: Other: Assessing the Effect Of Educational Intervention Based On Supportive Leadership Behavior on Iranian head nurses leadership performance | Arm Label: CONTROL; Type: PLACEBO_COMPARATOR; Interventions: Other: Assessing the Effect Of Educational Intervention Based On Supportive Leadership Behavior on Iranian head nurses leadership performance | Intervention Type: OTHER; Name: Assessing the Effect Of Educational Intervention Based On Supportive Leadership Behavior on Iranian head nurses leadership performance; Assigned to Arm(s): CONTROL, Educational Intervention
D: Arm Label: Intervention group; Type: ACTIVE_COMPARATOR; Interventions: Other: Education | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Education; Assigned to Arm(s): Intervention group

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effect of Vaginal Preparation With Chlorhexidine-alcohol vs. Povidine-iodine vs. Saline on Vaginal Bacteria Colony Counts in Pregnant Women
Brief Summary: The purpose of this study is to see whether chlorhexidine is superior to povidine-iodine vaginal antisepsis at reducing bacteria colony counts in pregnant women by comparing three groups: vaginal washing with chlorhexidine-alcohol, vaginal washing with povidine-iodine, and vaginal washing with saline alone.


Options:
A: Arm Label: Chlorhexidine - Isopropyl alcohol; Type: EXPERIMENTAL; Interventions: Drug: Chlorhexidine - Isopropyl alcohol | Arm Label: Povidone-Iodine Scrub and Paint; Type: EXPERIMENTAL; Interventions: Drug: Povidone-Iodine Scrub and Paint | Intervention Type: DRUG; Name: Chlorhexidine - Isopropyl alcohol; Assigned to Arm(s): Chlorhexidine - Isopropyl alcohol | Intervention Type: DRUG; Name: Povidone-Iodine Scrub and Paint; Assigned to Arm(s): Povidone-Iodine Scrub and Paint
B: Arm Label: Women going CS without vaginal preparation before surgery; Type: ACTIVE_COMPARATOR; Interventions: Other: No vaginal preparation before CS with Septal soap and septol. | Arm Label: Women going CS with vaginal preparation before surgery; Type: PLACEBO_COMPARATOR; Interventions: Other: vaginal preparation before CS with Septal soap and septol. | Intervention Type: OTHER; Name: vaginal preparation before CS with Septal soap and septol.; Assigned to Arm(s): Women going CS with vaginal preparation before surgery | Intervention Type: OTHER; Name: No vaginal preparation before CS with Septal soap and septol.; Assigned to Arm(s): Women going CS without vaginal preparation before surgery
C: Arm Label: Chlorhexidine-alcohol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Chlorhexidine-alcohol | Arm Label: Povidine-iodine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Povidine-iodine | Arm Label: Saline; Type: PLACEBO_COMPARATOR; Interventions: Drug: Sterile saline | Intervention Type: DRUG; Name: Chlorhexidine-alcohol; Assigned to Arm(s): Chlorhexidine-alcohol | Intervention Type: DRUG; Name: Povidine-iodine; Assigned to Arm(s): Povidine-iodine | Intervention Type: DRUG; Name: Sterile saline; Assigned to Arm(s): Saline
D: Arm Label: povidone iodine; Type: ACTIVE_COMPARATOR; Interventions: Drug: 10% povidone iodine | Arm Label: no vaginal cleansing; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: 10% povidone iodine; Assigned to Arm(s): povidone iodine

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Cognitive Outcomes and Response/Remission Efficacy of Convulsive Therapies for Bipolar Depression: the CORRECT-BD Trial
Brief Summary: This trial aims to assess the efficacy and tolerability of Magnetic Seizure Therapy (MST) as an alternative to electroconvulsive therapy (ECT) for Bipolar Disorder (BD). Research indicates that the prevalence of treatment resistance in bipolar depression is twice that of unipolar depression. The limited effectiveness of current treatments for bipolar depression coupled with the medical and economic burden associated with the disorder engenders a need for novel therapeutic interventions that can provide greater response and remission rates.


Options:
A: Arm Label: magnetic seizure therapy; Type: EXPERIMENTAL; Interventions: Device: Magpro X100 + Option, Other: treatment as usual (TAU) | Arm Label: electroconvulsive therapy; Type: ACTIVE_COMPARATOR; Interventions: Device: ThymatronSystem Ⅳ Electroconvulsive System, Other: treatment as usual (TAU) | Intervention Type: DEVICE; Name: Magpro X100 + Option; Assigned to Arm(s): magnetic seizure therapy | Intervention Type: DEVICE; Name: ThymatronSystem Ⅳ Electroconvulsive System; Assigned to Arm(s): electroconvulsive therapy | Intervention Type: OTHER; Name: treatment as usual (TAU); Assigned to Arm(s): electroconvulsive therapy, magnetic seizure therapy
B: Arm Label: Magnetic Seizure Therapy (MST); Type: EXPERIMENTAL; Interventions: Device: Magnetic Seizure Therapy | Arm Label: Electroconvulsive Therapy (ECT); Type: ACTIVE_COMPARATOR; Interventions: Device: Electroconvulsive Therapy | Intervention Type: DEVICE; Name: Magnetic Seizure Therapy; Assigned to Arm(s): Magnetic Seizure Therapy (MST) | Intervention Type: DEVICE; Name: Electroconvulsive Therapy; Assigned to Arm(s): Electroconvulsive Therapy (ECT)
C: Arm Label: Magnetic Seizure Therapy; Type: EXPERIMENTAL; Interventions: Device: Magnetic Seizure Therapy (MagPro MST) | Intervention Type: DEVICE; Name: Magnetic Seizure Therapy (MagPro MST); Assigned to Arm(s): Magnetic Seizure Therapy
D: Arm Label: Magnetic Seizure Therapy (MST); Type: EXPERIMENTAL; Interventions: Device: Magnetic Seizure Therapy (MST) | Arm Label: Electroconvulsive Therapy (ECT); Type: ACTIVE_COMPARATOR; Interventions: Device: Electroconvulsive Therapy (ECT) | Intervention Type: DEVICE; Name: Magnetic Seizure Therapy (MST); Assigned to Arm(s): Magnetic Seizure Therapy (MST) | Intervention Type: DEVICE; Name: Electroconvulsive Therapy (ECT); Assigned to Arm(s): Electroconvulsive Therapy (ECT)

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Controlled Trial of a Resilience Intervention for Critical Care Nurses
Brief Summary: The Corporate Athlete® Resilience (CAR) Training Program is a 1-day training program that uses a holistic approach that focuses on moving between stress and strategic recovery to help build resilience and enable higher performance.

The purpose of this RCT is to determine whether the CAR Training Program has significant impact on nurses' resilience and stress mindset in their personal lives and their working environment. Knowledge from this study can be applied to interventions in the future to improve resilience behavior.


Options:
A: Arm Label: Electronic intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Electronic intervention suggesting behavioral activity | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Electronic intervention suggesting behavioral activity; Assigned to Arm(s): Electronic intervention
B: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Corporate Athlete Resilience (CAR) Training Program | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Corporate Athlete Resilience (CAR) Training Program; Assigned to Arm(s): Intervention
C: Arm Label: A treatment based on CBT and new technologies; Type: EXPERIMENTAL; Interventions: Behavioral: Coping skills and relaxation training with new technologies | Arm Label: Traditional treatment based on CBT; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Traditional coping skills and relaxation training | Intervention Type: BEHAVIORAL; Name: Coping skills and relaxation training with new technologies; Assigned to Arm(s): A treatment based on CBT and new technologies | Intervention Type: BEHAVIORAL; Name: Traditional coping skills and relaxation training; Assigned to Arm(s): Traditional treatment based on CBT
D: Arm Label: Control group; Type: N/A; Interventions: Other: questionnaire to define the presence of job strain at 6 months, Other: questionnaire to define the presence of job strain at 12 months | Arm Label: Simulation group; Type: N/A; Interventions: Other: Simulation during the study (5-day specific training with dedicated scenario done by an ICU expert simulation team), Other: questionnaire to define the presence of job strain at 6 months, Other: questionnaire to define the presence of job strain at 12 months | Intervention Type: OTHER; Name: Simulation during the study (5-day specific training with dedicated scenario done by an ICU expert simulation team); Assigned to Arm(s): Simulation group | Intervention Type: OTHER; Name: questionnaire to define the presence of job strain at 6 months; Assigned to Arm(s): Control group, Simulation group | Intervention Type: OTHER; Name: questionnaire to define the presence of job strain at 12 months; Assigned to Arm(s): Control group, Simulation group

Answer: B